» Authors » Andrew J Gawron

Andrew J Gawron

Explore the profile of Andrew J Gawron including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 77
Citations 1004
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gawron A, Bailey T, Codden R, Dominitz J, Gupta S, Helfrich C, et al.
Contemp Clin Trials . 2024 Dec; 149:107784. PMID: 39730079
Background: Colorectal cancer (CRC) prevention is a Veterans Affairs (VA) priority. Colonoscopy quality, especially adenoma detection rate (ADR), is critical for effective screening. Our research indicates considerable variation in ADR...
2.
Gawron A, McKee G, Dominitz J, Yao Y, Whooley M, Kaltenbach T
Clin Gastroenterol Hepatol . 2024 Aug; PMID: 39209190
No abstract available.
3.
Shah I, Gawron A, Byrne K, Inadomi J
Gastroenterology . 2024 Mar; 166(4):549-552. PMID: 38521575
No abstract available.
4.
Shah I, Gawron A, Byrne K, Inadomi J
Clin Gastroenterol Hepatol . 2024 Mar; 22(4):679-683. PMID: 38519261
No abstract available.
5.
Toy G, Colletier K, Hale G, Valentine J, Gawron A, Sossenheimer M, et al.
Endosc Int Open . 2023 Aug; 11(7):E653-E659. PMID: 37614326
In gastrointestinal endoscopy, biopsies must transit through the accessory channel and cap, presenting an opportunity for loss of tissue. We sought to determine the incidence of specimen retention in the...
6.
Robertson D, Dominitz J, Beed A, Boardman K, Del Curto B, Guarino P, et al.
JAMA Netw Open . 2023 Jul; 6(7):e2321730. PMID: 37432690
Importance: The Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) randomized clinical trial sought to recruit 50 000 adults into a study comparing colorectal cancer (CRC)...
7.
Joo Y, Pacheco J, Thompson W, Rasmussen-Torvik L, Rasmussen L, Lin F, et al.
PLoS One . 2023 May; 18(5):e0283553. PMID: 37196047
Objective: Diverticular disease (DD) is one of the most prevalent conditions encountered by gastroenterologists, affecting ~50% of Americans before the age of 60. Our aim was to identify genetic risk...
8.
Gupta S, Earles A, Bustamante R, Patterson O, Gawron A, Kaltenbach T, et al.
Clin Gastroenterol Hepatol . 2022 Oct; 21(7):1924-1936.e9. PMID: 36270618
Background And Aims: Postpolypectomy risk stratification for subsequent metachronous advanced neoplasia (MAN) is imprecise and does not account for colonoscopist adenoma detection rate (ADR). Our aim was to assess association...
9.
Trivedi M, Godil S, Demb J, Earles A, Bustamante R, Patterson O, et al.
Clin Gastroenterol Hepatol . 2022 Oct; 21(6):1637-1645. PMID: 36243354
Background And Aims: Traditional serrated adenomas (TSAs) may confer increased risk for colorectal cancer (CRC). Our objective with this study was to examine clinical characteristics and long-term outcomes associated with...
10.
Demb J, Liu L, Bustamante R, Dominitz J, Earles A, Shah S, et al.
Dig Dis Sci . 2022 Sep; 68(4):1208-1217. PMID: 36169748
Background: Delays in colonoscopy work-up for red flag signs or symptoms of colorectal cancer (CRC) during the COVID-19 pandemic are not well characterized. Aims: To examine colonoscopy uptake and time...